Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Xu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Analytical Chemistry|April 29, 2025
Simultaneous Analysis of the Drug-to-Antibody Ratio, Free-Drug-Related Impurities, and Purity of Antibody-Drug Conjugates Based on Size Exclusion ChromatographyWoran Song, Lifeng Yin, Jun Ren, et al.
Scientific Reports|July 13, 2016
Fully Mechanically Controlled Automated Electron Microscopic TomographyJinxin Liu, Hongchang Li, Lei Zhang, et al.
Biotechnology Journal|August 13, 2025
Tailoring Plasmid Design Based on Chain Expression in Cell Line Development for Enhanced Monoclonal and Bispecific Antibody ProductionShenghai Liu, Qianqian Chen, Lujia Peng, et al.
Bioconjugate Chemistry|June 4, 2026
A Case Study on the Impact of Thermal Hydrolysis and Lactone Ring Opening of Linker-Payload on Drug-to-Antibody Ratio Determination in a Topoisomerase I Inhibitor-Based ADCKeying Liang, Xiaotong Zhou, Henghui Li, et al.
Mabs|May 25, 2023
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activityMeiqi Yi, Jian Sun, Hanzi Sun, et al.
Nature Structural Biology|December 7, 2002
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclusteringSamuel Davis, Nick Papadopoulos, Thomas H Aldrich, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Analytical Chemistry|April 29, 2025
Simultaneous Analysis of the Drug-to-Antibody Ratio, Free-Drug-Related Impurities, and Purity of Antibody-Drug Conjugates Based on Size Exclusion ChromatographyWoran Song, Lifeng Yin, Jun Ren, et al.
Scientific Reports|July 13, 2016
Fully Mechanically Controlled Automated Electron Microscopic TomographyJinxin Liu, Hongchang Li, Lei Zhang, et al.
Biotechnology Journal|August 13, 2025
Tailoring Plasmid Design Based on Chain Expression in Cell Line Development for Enhanced Monoclonal and Bispecific Antibody ProductionShenghai Liu, Qianqian Chen, Lujia Peng, et al.
Bioconjugate Chemistry|June 4, 2026
A Case Study on the Impact of Thermal Hydrolysis and Lactone Ring Opening of Linker-Payload on Drug-to-Antibody Ratio Determination in a Topoisomerase I Inhibitor-Based ADCKeying Liang, Xiaotong Zhou, Henghui Li, et al.
Mabs|May 25, 2023
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activityMeiqi Yi, Jian Sun, Hanzi Sun, et al.
Nature Structural Biology|December 7, 2002
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclusteringSamuel Davis, Nick Papadopoulos, Thomas H Aldrich, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Pageof 2